Loading…
Phio Pharmaceuticals Corp. is projected to rise to $1.16 by 2027, a +12% move from its current price of $1.03. PHIO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.992 | $1.03 | $1.07 | +0.02% |
| Aug 6 | $0.9768 | $1.03 | $1.09 | +0.05% |
| Aug 7 | $0.9654 | $1.03 | $1.10 | +0.07% |
| Aug 8 | $0.9559 | $1.03 | $1.11 | +0.10% |
| Aug 9 | $0.9476 | $1.03 | $1.12 | +0.12% |
| Aug 10 | $0.9402 | $1.03 | $1.13 | +0.15% |
| Aug 11 | $0.9335 | $1.03 | $1.14 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.9335 | $1.03 | $1.14 | +0.17% |
| Week 2 | $0.8971 | $1.03 | $1.19 | +0.35% |
| Week 3 | $0.8705 | $1.04 | $1.23 | +0.52% |
| Week 4 | $0.8489 | $1.04 | $1.27 | +0.70% |
| Week 5 | $0.8305 | $1.04 | $1.30 | +0.87% |
| Week 6 | $0.8144 | $1.04 | $1.33 | +1.05% |
| Week 7 | $0.7999 | $1.04 | $1.36 | +1.23% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Phio Pharmaceuticals Corp. is a clinical stage biopharmaceutical company focused on immuno-oncology therapeutics in the United States.
It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound designed to silence BRD4, in preclinical studies.
The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.
PHIO currently trades at $0.9842 with a market cap of $11.43M and is ranked 5046.
The near-term outlook is anchored by the 2026 forecast, which shows an average price of $0.9842 with a neutral sentiment.
Beyond 2026, the forecast projects a bullish trajectory with the 2027 average of $1.11 and a 13.2% ROI, rising toward the late 2020s and into 2030s, with the 2030 average at $1.34 and notable long-term upside. The forecast also shows 2040 with an average of $2.15 and 118.7% ROI, and 2050 with an average of $3.83 and 289.4% ROI.
A major floor 24.8% below — a decisive break under it would weaken the trend.
The nearest floor, 13.6% below — buyers have tended to step in here.
The nearest ceiling, 9.7% above — a clean break opens room to run.
A major ceiling 28.2% above — clearing it would confirm fresh momentum.
Key PHIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PHIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.02 | Buy | $1.02 | Buy |
| MA 10 | $1.05 | Sell | $1.03 | Buy |
| MA 20 | $1.03 | Buy | $1.03 | Sell |
| MA 50 | $1.05 | Sell | $1.06 | Sell |
| MA 100 | $1.13 | Sell | $1.12 | Sell |
| MA 200 | $1.22 | Sell | $1.34 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.89 | Neutral |
| Stoch RSI (14) | 59.74 | Neutral |
| CCI (20) | -7.03 | Neutral |
| Williams %R (14) | -43.75 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 15.17 | Buy |
| Bollinger %B (20,2) | 0.48 | Neutral |
| Stochastic %K (14) | 56.25 | Neutral |
| TRIX (15) | -0.06 | Sell |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 44.39 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 1.00 | Buy |
| ADX (14) | 8.67 | Neutral |
| ATR (14) | 0.04 | Info |
The 30-day technical picture is Bearish.
RSI(14) is 40, indicating modest near-term momentum weakness. The 50-day simple moving average is $1.05 and the 200-day simple moving average is $1.23, framing resistance below the longer-term trend.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.857 | $1.03 | $1.25 | 0% | Neutral | |
| $0.89 | $1.16 | $1.61 | +12% | Neutral | |
| $0.9949 | $1.35 | $1.97 | +31% | Bullish | |
| $1.04 | $1.46 | $2.21 | +42% | Bullish | |
| $0.9669 | $1.40 | $2.18 | +36% | Bullish | |
| $0.8909 | $1.32 | $2.13 | +28% | Bullish | |
| $0.8805 | $1.34 | $2.21 | +30% | Bullish | |
| $0.9066 | $1.42 | $2.39 | +37% | Bullish | |
| $1.12 | $1.78 | $3.07 | +73% | Bullish | |
| $1.17 | $1.92 | $3.36 | +86% | Bullish | |
| $1.25 | $2.28 | $4.32 | +122% | Bullish | |
| $1.85 | $4.07 | $8.61 | +296% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.857 | $1.03 | $1.23 | +0.00% |
| September 2026 | $0.8425 | $1.01 | $1.25 | -2.22% |
| October 2026 | $0.8728 | $1.05 | $1.32 | +4.61% |
| November 2026 | $0.8568 | $1.04 | $1.32 | -1.06% |
| December 2026 | $0.7949 | $0.9742 | $1.25 | -6.55% |
Click any year to see its month-by-month PHIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, PHIO could reach as high as $1.25, with a base case around $1.03 and support toward $0.857 — roughly 0% from $1.03. A consolidation phase looks the most probable path here.
Expect PHIO to range from $0.89 to $1.61 through 2027. The $1.16 average target implies a +12% move from current prices. That is up +12% on the projected 2026 average. Price action looks broadly range-bound.
The PHIO price prediction for 2028 points to an average of $1.35 (low $0.9949, high $1.97) — a potential gain of +31% on today's $1.03. Buyers look set to stay in control over this stretch.
In 2029, PHIO is projected to trade between $1.04 and $2.21, averaging $1.46 — a potential gain of +42% from today's $1.03. That is up +8% on the projected 2028 average. Momentum favours further upside here.
Phio Pharmaceuticals Corp.'s 2030 outlook centres on $1.40, within a $0.9669 to $2.18 range. That is -4% versus the projected 2029 average. That marks a +36% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, PHIO could reach as high as $2.13, with a base case around $1.32 and support toward $0.8909 — roughly +28% from $1.03. Momentum favours further upside here.
Expect PHIO to range from $0.8805 to $2.21 through 2032. The $1.34 average target implies a +30% move from current prices. That is up +1% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The PHIO price prediction for 2033 points to an average of $1.42 (low $0.9066, high $2.39) — a potential gain of +37% on today's $1.03. Momentum favours further upside here.
In 2034, PHIO is projected to trade between $1.12 and $3.07, averaging $1.78 — a potential gain of +73% from today's $1.03. That is up +26% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Phio Pharmaceuticals Corp.'s 2035 outlook centres on $1.92, within a $1.17 to $3.36 range. That is up +7% on the projected 2034 average. That marks a +86% change versus current levels. Momentum favours further upside here.
By 2040, PHIO could reach as high as $4.32, with a base case around $2.28 and support toward $1.25 — roughly +122% from $1.03. Buyers look set to stay in control over this stretch.
Expect PHIO to range from $1.85 to $8.61 through 2050. The $4.07 average target implies a +296% move from current prices. That is up +79% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in PHIO today (≈ 970.873786 PHIO) could be worth
$3,955.5
+$2,955.5 (+296%) by 2050 · US Dollar
Based on the average projected PHIO price of $4.07 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PHIOwould be worth at today's price.
$1,000 invested in PHIO on Jul 31, 2025 (≈ 420.168047 PHIO) would be worth
$432.77
-$567.23 (-56.7%) today · 0.43× · US Dollar
Based on a PHIO entry price of $2.38 vs. today's $1.03.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.04 | $990.38 | -1.0% |
| 1 month ago | $1 | $1,030 | +3.0% |
| 3 months ago | $1.14 | $903.51 | -9.6% |
| 6 months ago | $0.987 | $1,043.57 | +4.4% |
| 1 year ago | $2.38 | $432.77 | -56.7% |
| All time (5.0y) ago | $196.56 | $5.24 | -99.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PHIO forecast.
Our base-case forecast reaches $2.10 around 2040.
Implied market cap at $2.10: $24.4M
The multi-year forecast shows a shift from neutral in 2026 to bullish sentiment from 2028 onward.
From 2027 onward, the forecast shows a bullish path, with 2027 average $1.11 and 13.2% ROI, 2028 average $1.28, 2029 $1.39, and 2030 $1.34 with 36.1% ROI. The outlook continues with 2031 $1.25, 2032 $1.27, 2033 $1.35, 2034 $1.68 with 70.7% ROI, and 2035 $1.82 with 85.1% ROI.
Longer-range projections extend to 2040 with an average of $2.15 and 118.7% ROI, and to 2050 with an average of $3.83 and 289.4% ROI.
These figures are estimates, not guarantees, and depend on market conditions and other factors.
Tap a question to reveal the answer.
The 2030 forecast lists an average price of $1.34 with a max of $2.11, a min of $0.9211, and a 36.1% ROI, with bullish sentiment.
The forecast shows a bullish path from 2028 onward, with rising averages and ROIs (e.g., 2040 ROI 118.7% and 2050 ROI 289.4%), but these are estimates, not guarantees.
The 2050 forecast shows a max of $8.20 and an average of $3.83, indicating that values above $5 could occur in the long term within the forecast range, but not guaranteed.
PHIO is currently $0.9842 with a market cap of $11.43M and is ranked 5046.
The 30-day range is $0.7616 to $1.27, RSI(14) is 40, 50-day SMA is $1.05, 200-day SMA is $1.23, with support at $0.89 and resistance at $1.13.
Phio Pharmaceuticals Corp. Community Discussion
0Share your Phio Pharmaceuticals Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.